ABTAA’s unique ability to bind and cluster ANGPT2 into a potent TIE2 activator helps to prevent endothelial dysfunction, tubular injury, and tubulointerstitial fibrosis in experimental CKD. Here, ANGPT2 is linked to chronic kidney disease.